147 related articles for article (PubMed ID: 21167177)
21. Structural and biochemical studies of human lysine methyltransferase Smyd3 reveal the important functional roles of its post-SET and TPR domains and the regulation of its activity by DNA binding.
Xu S; Wu J; Sun B; Zhong C; Ding J
Nucleic Acids Res; 2011 May; 39(10):4438-49. PubMed ID: 21266482
[TBL] [Abstract][Full Text] [Related]
22. Structural Basis for Substrate Preference of SMYD3, a SET Domain-containing Protein Lysine Methyltransferase.
Fu W; Liu N; Qiao Q; Wang M; Min J; Zhu B; Xu RM; Yang N
J Biol Chem; 2016 Apr; 291(17):9173-80. PubMed ID: 26929412
[TBL] [Abstract][Full Text] [Related]
23. E. coli 5'-nucleotidase undergoes a hinge-bending domain rotation resembling a ball-and-socket motion.
Knöfel T; Sträter N
J Mol Biol; 2001 May; 309(1):255-66. PubMed ID: 11491294
[TBL] [Abstract][Full Text] [Related]
24. SMYD3-NY, a novel SMYD3 mRNA transcript variant, may have a role in human spermatogenesis.
Zhou Z; Ren X; Huang X; Lu L; Xu M; Yin L; Li J; Sha J
Ann Clin Lab Sci; 2005; 35(3):270-7. PubMed ID: 16081583
[TBL] [Abstract][Full Text] [Related]
25. SMYD proteins: key regulators in skeletal and cardiac muscle development and function.
Du SJ; Tan X; Zhang J
Anat Rec (Hoboken); 2014 Sep; 297(9):1650-62. PubMed ID: 25125178
[TBL] [Abstract][Full Text] [Related]
26. Insights into the mechanism of domain closure and substrate specificity of glutamate dehydrogenase from Clostridium symbiosum.
Stillman TJ; Migueis AM; Wang XG; Baker PJ; Britton KL; Engel PC; Rice DW
J Mol Biol; 1999 Jan; 285(2):875-85. PubMed ID: 9878450
[TBL] [Abstract][Full Text] [Related]
27. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
28. An archaeal SET domain protein exhibits distinct lysine methyltransferase activity towards DNA-associated protein MC1-alpha.
Manzur KL; Zhou MM
FEBS Lett; 2005 Jul; 579(17):3859-65. PubMed ID: 15978576
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional studies of the yeast class II Hda1 histone deacetylase complex.
Lee JH; Maskos K; Huber R
J Mol Biol; 2009 Aug; 391(4):744-57. PubMed ID: 19573535
[TBL] [Abstract][Full Text] [Related]
30. Inducible covalent posttranslational modification of histone H3.
Bode AM; Dong Z
Sci STKE; 2005 Apr; 2005(281):re4. PubMed ID: 15855410
[TBL] [Abstract][Full Text] [Related]
31. Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells.
Luo XG; Zou JN; Wang SZ; Zhang TC; Xi T
IUBMB Life; 2010 Mar; 62(3):194-9. PubMed ID: 20039369
[TBL] [Abstract][Full Text] [Related]
32. The active site of the SET domain is constructed on a knot.
Jacobs SA; Harp JM; Devarakonda S; Kim Y; Rastinejad F; Khorasanizadeh S
Nat Struct Biol; 2002 Nov; 9(11):833-8. PubMed ID: 12389038
[TBL] [Abstract][Full Text] [Related]
33. Explaining the autoinhibition of the SMYD enzyme family: A theoretical study.
Al-Shar'i NA; Alnabulsi SM
J Mol Graph Model; 2016 Jul; 68():147-157. PubMed ID: 27447830
[TBL] [Abstract][Full Text] [Related]
34. Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase.
Qian C; Wang X; Manzur K; Sachchidanand ; Farooq A; Zeng L; Wang R; Zhou MM
J Mol Biol; 2006 May; 359(1):86-96. PubMed ID: 16603186
[TBL] [Abstract][Full Text] [Related]
35. Structural snapshots of the KMSKS loop rearrangement for amino acid activation by bacterial tyrosyl-tRNA synthetase.
Kobayashi T; Takimura T; Sekine R; Kelly VP; Kamata K; Sakamoto K; Nishimura S; Yokoyama S
J Mol Biol; 2005 Feb; 346(1):105-17. PubMed ID: 15663931
[TBL] [Abstract][Full Text] [Related]
36. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
Kunizaki M; Hamamoto R; Silva FP; Yamaguchi K; Nagayasu T; Shibuya M; Nakamura Y; Furukawa Y
Cancer Res; 2007 Nov; 67(22):10759-65. PubMed ID: 18006819
[TBL] [Abstract][Full Text] [Related]
37. Histone-modifying enzymes: encrypting an enigmatic epigenetic code.
Couture JF; Trievel RC
Curr Opin Struct Biol; 2006 Dec; 16(6):753-60. PubMed ID: 17070031
[TBL] [Abstract][Full Text] [Related]
38. Catalytic strategy of S-adenosyl-L-homocysteine hydrolase: transition-state stabilization and the avoidance of abortive reactions.
Yang X; Hu Y; Yin DH; Turner MA; Wang M; Borchardt RT; Howell PL; Kuczera K; Schowen RL
Biochemistry; 2003 Feb; 42(7):1900-9. PubMed ID: 12590576
[TBL] [Abstract][Full Text] [Related]
39. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
